NCPA Applauds FTC Pick for Associate Director of Health Care

Key Takeaways

The NCPA supports the FTC's appointment of Emma Mittelstaedt Burnham, emphasizing her experience in investigating anticompetitive practices.
Fair competition in healthcare is crucial, with concerns about PBMs and insurers manipulating the system to their advantage.
The NCPA has a longstanding collaboration with the FTC and actively participates in litigation against PBMs for anticompetitive practices.

Emma Mittelstaedt Burnham is an experienced antitrust enforcer, exactly what patients and providers need to go up against PBMs and insurers.

ALEXANDRIA, Va. (Sept. 10, 2025) – The National Community Pharmacists Association issued the following statement on behalf of CEO B. Douglas Hoey in response to Federal Trade Commission Chairman Andrew Ferguson’s decision to hire Emma Mittelstaedt Burnham as associate director of health care in the agency’s Bureau of Competition:

“Fair competition is essential in the health care sector. Without it, powerful companies like PBMs and insurers manipulate the system in their own favor, and at the expense of consumers, patients, taxpayers, and small providers like independent pharmacies. Ms. Mittelstaedt Burnham has extensive experience investigating bad actors as an attorney with the DOJ, and we expect her to direct that focus to PBMs, where it is badly needed.”

NCPA has worked closely with the FTC on antitrust matters for years. It is also active in state and federal courts supporting litigation against pharmacy benefit managers for their anticompetitive practices.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!